AMBER BERLEEN: Open Payments
NPI 1851890222 · GLENDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,977 in 171 payments from 43 companies in 2025. Trend: 2023 $2,542 · 2024 $2,986 · 2025 $4,977
Food & beverage: $3,835Honoraria: $700Travel & lodging: $375Education: $66
| Company | Payments | Amount |
|---|---|---|
| CATALYST PHARMACEUTICALS, INC. | 3 | $1,152 |
| AstraZeneca Pharmaceuticals LP | 13 | $319 |
| Merck Sharp & Dohme LLC | 11 | $294 |
| Novartis Pharmaceuticals Corporation | 12 | $259 |
| JAZZ PHARMACEUTICALS INC. | 4 | $234 |
| PFIZER INC. | 12 | $227 |
| Janssen Biotech, Inc. | 10 | $205 |
| ABBVIE INC. | 16 | $189 |
| Incyte Corporation | 8 | $175 |
| Daiichi Sankyo Inc. | 7 | $146 |
Products named: FIRDAPSE, KEYTRUDA, EPKINLY, ZIIHERA, ZEPZELCA, OPDIVO, ENHERTU, IBRANCE.
Industry payments across AZ — which companies pay providers there.
